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Introduction 
Hereditary hemochromatosis (HH) is a genetic disorder character-
ized by increased intestinal absorption of dietary iron and iron re-
lease from reticuloendothelial macrophages. The excess of iron 
entry into the bloodstream results in iron deposition in parenchymal 
organs such as liver, pancreas, heart and pituitary glands, which 
subsequently leads to tissue damage and ultimately to cirrhosis, 
diabetes, cardiomyopathy, hypogonadism, arthropathy and skin 
pigmentation [1,2]. Although iron is essential for critical cellular 
functions, the excess may catalyze Haber-Weiss reactions that 
generate reactive oxygen species (ROS) leading to consequent 
damage to DNA, proteins and membranes. The increase of lipid 
peroxidation, catalyzed by iron, has been proposed as an initial step 
by which excess iron causes cellular injury [3]. 
The majority of the patients with HH are homozygous for the muta-
tion c.845G>A (p.Cys282Tyr) in the HFE gene (HH type 1), being 
the clinical and biochemical penetrance highly variable [4-6]; the 
non-HFE hemochromatosis are caused by mutations in different 
genes involved in iron homeostasis [7]. 
The hepatic iron accumulation is also a pathological trait of different 
disorders, and it is often observed in patients with Porphyria Cuta-
nea Tarda (PCT). PCT is the most common type of porphyria. PCT 
is caused by subnormal activity of uroporphyrinogen decarboxylase 
(URO-D), the fifth enzyme of heme biosynthetic pathway [8]. The 
disease is characterized by skin photosensitivity with blistering on 
sun-exposed areas, skin fragility, hyperpigmentation, and hyper-
thricosis [9,10]. The clinical manifestations are frequently associat-
ed with exposure to precipitating agents, e.g. alcohol, estrogen, 
polyhalogenated aromatic hydrocarbons, iron overload and virus 
infection (hepatitis C virus, human immunodeficiency virus, and less 
frequently, hepatitis B virus [10,12]. 
Edwards, et al [13] were the first to suggest that mutations in the 
HFE gene were responsible for the hepatic siderosis in many pa-
tients with PCT. This was later confirmed by mutational analysis of 
the HFE gene [14]. 
Isoflurane is a volatile anaesthetic used in clinical medicine to pro-
duce general anaesthesia. This drug is metabolized by cytochrome 
P-450 (CYP) and in particular by the isoform CYP2E1 [15]. We 
have previously demonstrated that Isoflurane produced significant 
alterations in heme metabolism and its regulation in a way depend-
ent on sex and strain when it was administered to mice [16,17]. 
Furthermore, this anesthetic caused changes in the antioxidant 
defense system and in the expression of Nitric Oxide Synthase 
(NOS) [18-20]. Moreover, in alcoholized mice, Isoflurane admin-
istration also altered Phase I drug metabolizing system [21]. The 
effects of this anesthetic in mice models of Erythropoietic Protopor-
phyria and Porphyria Hepatoerythropoietic indicated that admin-
istration should be avoided not only in patients with acute porphy-
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rias [16] but it should be used with caution in patients with non-
acute hepatic porphyrias [22,23]. 
The aim of this work was to characterize oxidative and nitrosative 
stress status and its relationship with heme metabolism alterations 
in a mouse model of hemochromatosis, and to evaluate the chang-
es caused by the administration of Isoflurane. Taking into account 
the known association between HH and PCT it was of interest to 
investigate the effect of the porphyrinogenic drug, ethanol, in this 
model of HH. The results were compared with those produced un-
der the pathological situation of elevated accumulation of the pre-
cursor of heme biosynthesis 5-aminolevulinic acid (ALA). A compar-
ative study between male and female mice was performed. 
To evaluate the stress oxidative status, the levels of reduced 
gluthation (GSH), total antioxidant capacity (TAC), and the activities 
of Catalase and Superoxide dismutase (SOD) were measured. As a 
marker of nitrosative stress, the expression of NOS was deter-
mined. Heme metabolism was studied through the activities of 5-
Aminolevulinic acid synthase (ALA-S), the regulatory enzyme; Por-
phobilinogen deaminase (PBG-D), enzyme reduced in the Acute 
Intermittent Porphyria (AIP) and Heme oxygenase (HO), involved in 
heme catabolism and also augmented under oxidative stress [24]. 
Moreover, it was of interest to determine if the drug metabolizing 
system was altered, so the activity of the CYP2E1 enzyme respon-
sible of Isoflurane and ethanol Phase I metabolization; and Glutha-
tion S-transferase (GST), involved in Phase II reactions as a marker 
of hepatic damage [25] were determined. 
Materials and Methods 
Animals 
The hemochromatic mice Hfe−/− (strain B6 129P2-Hfetm1gfn ⁄J 
from The Jackson Laboratory) and wild-type mice, both on a 
C57BL/6J background, were bred under specific pathogen-free 
conditions at the animal facility of the Hospital 12 de Octubre, Ma-
drid, Spain, with unlimited water supply and a maintenance irradiat-
ed diet. The animal experimentation was conducted in accordance 
with “European Council Guidelines” (86/609 CEE, 90/67 CEE, 
99/575 CEE) and the Spanish Royal Decree 1201/2005. 
Experimental Design 
Male and female 8-week-old mice of both genotypes, Hfe−/− and 
wild-type, were divided in groups of 4-6 animals that received the 
following treatments: One group received a single dose of 2 ml/kg 
(0.6:3, v/v. in oil) i.p, of Isoflurane. This was the optimum anaesthet-
ic dose to produce more alterations in the heme pathway, as was 
previously described [16]. Other group received ethanol (30% in 
drinking water during a week), and a third group was treated with a 
single dose of ALA (40 mg ALA/kg in NaCl 0.9%, pH 7; i.p). Control 
animals received the vehicle and they were sacrificed at the same 
times corresponding to each treatment. 
Tissue Extraction and Assays 
All groups of mice were sacrificed at the same time of the day. 
Blood was obtained by cardiac puncture and collected in heparin-
ised tubes. A liver sample was excised previous to perfusion to 
assess subsequently the enzymatic activity of ALA-S [26], to quanti-
fy ALA [27] and the expression of inducible NOS (iNOS) with a spe-
cific antibody (Anti iNOS/NOS II H-174, Santa Cruz Biotechnology, 
Inc.) [20]. Mice were then perfused through the heart with 20 ml of 
physiological solution before liver was removed. Liver samples were 
excised and immediately homogenized in sucrose 0.25 M and cen-
trifuged at 10,000 g for 20 minutes at 4ºC. The supernatant ob-
tained was used to quantified the levels of GSH [28] and TAC 
(Innoprot kit P40117, Innovative Technologies in Biological Systems 
S.L., Bizkaia, Spain), and to assess the enzymatic activities of PBG
-D [29], HO [30], Catalase [31] and GST [32]. This first supernatant 
was then ultracentrifuged at 100,000 g for 60 minutes at 4ºC, the 
supernatant thus obtained was used to assess SOD activity 
(Innoprot kit P40118, Innovative Technologies in Biological Systems 
S.L., Bizkaia, Spain) and the resultant pellet was used for measur-
ing CYP2E1 activity [33]. Protein concentration was measured by 
Bio-Rad DC Protein Assay (Bio-Rad Laboratories, München, Ger-
many). 
Statistical Analysis 
The results were expressed as mean and standard deviation (s.d.). 
The analysis of the variance test (ANOVA) was used to establish 
the differences between groups and p<0.05 was considered as 
significant. 
Results 
Oxidative and Nitrosative Stress Parameters 
In [Table-1] are shown the results obtained when basal levels of 
oxidative stress markers were measured in the mice model of he-
mochromatosis and compared with that of wild type mice. 
TAC values were similar in wild type and Hfe-/- mice of both females 
and males. Although, if we compare between sex, wild type or Hfe-/, 
the females showed higher levels than male groups (25%, p<0.05). 
Table 1- Basal levels of oxidative stress markers 
GSH basal levels were reduced in male Hfe-/- mice (28%, p<0.05) 
respect to wild type group. This difference was not observed in the 
groups of females. When we compare the values of males and 
females, GSH was higher in both female groups: control (45%, 
p<0.05) and Hfe-/- (70%, p<0.05) than the respective male group.  
The differences of basal SOD activity between wild type and Hfe-/-
groups were no significant. 
Catalase activity was also diminished in the Hfe-/- group, males 
(27%, p<0.05) or females (40%, p<0.05) mice, without any differ-
ence between sex. 
The results obtained when animals received Isoflurane, ethanol or 
ALA are shown in [Fig-1]. 
In animals treated with Isoflurane no significant differences were 
found in any of the studied parameters related with antioxidant de-
fence system in both males and females [Fig-1a]. 
When the effect of ethanol was evaluated an increase of Catalase 
activity was produced in males (96%, p<0.05) and females (58%, 
p<0.05) Hfe-/- group. TAC and GSH levels remained unaltered. An 
increase in SOD activity (65%, p<0.05) was only observed in male 
Hfe-/- group by the action of this xenobiotic [Fig-1b]. 
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62 ± 14 25.19 ± 3.91 0.092 ± 0.035 44.57 ± 15.11 
Hfe-/- 55 ± 15 18.33 ± 7.57* 0.086 ± 0.028 32.33 ± 8.87* 
Control 
Females  
79 ± 7** 36.48 ± 6.15** 0.080 ± 0.007 53.12 ± 15.70 
Hfe-/- 69 ± 11** 31.35 ±  5.23** 0.069 ± 0.011 31.59 ± 5.54* 
*p<0.05: significance of differences between Hfe-/- group respect to control group. 
**p<0.05: significance of differences between males and females groups. 
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ALA administration reduced 35% (p<0.05) GSH levels in control 
male group. Moreover, SOD activity was increased in hemochro-
matic male mice, effect not observed in females [Fig-1c]. 
Fig. 1- Oxidative stress markers in animals treated with Isoflurane 
(a); ethanol (b); and ALA (c). 
No treated animals.      Treated animals. TAC: Total 
antioxidant capacity, GSH: reduced gluthatione, CAT: Catalase, 
SOD: Superoxide dismutase. Data represent mean value ± s.d. of 
at least 4-6 animals. p<0.05, significance of differences between 
treated and non treated mice. 
To evaluate the instauration of nitrosative stress, iNOS expression 
was measured. No significant differences were observed between 
control and Hfe-/- (data not shown). When Isoflurane was adminis-
tered to control group, a diminution of 35% (p<0.05) in iNOS was 
produced; this effect was not detected when the anaesthetic was 
administered to Hfe-/- [Fig-2]. iNOS expression was unchanged by 
administration of ethanol or ALA in all the groups studied (data not 
shown). 
Heme Metabolism Parameters 
[Table-2] shows basal levels of some parameters involved in heme 
metabolism in control and Hfe-/- groups. No significant differences 
were observed in ALA levels between both groups, in spite that ALA
-S activity was 2 fold (p<0.05) higher in Hfe-/- mice, male and fe-
males, respect to wild type group. PBG-D activity was slightly ele-
vated (27%, p<0.05) in Hfe-/-, but this difference was only observed 
in the males. The basal activity of HO in male Hfe-/- was 37% 
(p<0.05) lower than controls; without no differences between female 
groups. 
Fig. 2- Expression of NOS-1 in control, Hfe-/- group treated or not 
with Isoflurane. 
Western Blot bands were on the top panel. On the bottom panel, 
columns represent normalized signals in the control and treated 
animals that were quantified using an Image Analyzer. Values are 
expressed as mean of at least three determinations run in duplicate 
and are expressed as a percentage taking the control group as 
100%. (*) p<0.05, significance of differences between treated and 
non treated mice.  
Table 2- Basal levels of heme metabolism parameters 
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0.091 ± 0.017  0.092 ± 0.012 0.329 ± 0.031  0.717 ± 0.374 
Hfe-/- 0.086 ± 0.019  0.190 ± 0.042* 0.407 ± 0.044* 0.452 ± 0.138* 
Control 
Females  
0.060 ± 0.007  0.073 ± 0.013 0.381 ± 0.003 0.654 ± 0.085 
Hfe-/- 0.087 ± 0.019  0.156 ± 0.036* 0.442 ± 0.071 0.662 ± 0.159 
*p<0.05, significance of differences between Hfe-/- group respect to control group 
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When we compare these parameters between sex, no significant 
differences were observed in basal levels of ALA, ALA-S and PBG-
D, although HO activity was in females 46% (p<0.05) greater in 
females than in males. 
The results obtained when animals received Isoflurane, ethanol or 
ALA are shown in [Fig-3]. 
When the effects of Isoflurane were evaluated, only the activity of 
PBG-D was 20% (p<0.05) diminished in males and females Hfe-/- 
mice. Moreover, HO activity was 45% (p<0.05) increased in male 
mice, without any alteration in the other groups of mice. ALA levels 
and ALA-S activity were also unchanged after anaesthetic admin-
istration [Fig-3a]. 
Fig. 3- Heme metabolism parameters in animals treated with Isoflu-
rane (a); ethanol (b); and ALA (c). 
No treated animals.         Treated animals. ALA-S: 5-
Aminolevulinic acid synthetase. ALA: 5-Aminolevulinic acid, PBG-D: 
Porphobilinogen deaminase, HO: Heme oxygenase. Data represent 
mean value ± s.d. of at least 4-6 animals. p<0.05, significance of 
differences between treated and non treated mice.  
When ethanol was administered a 30% (p<0,05) reduction of PBG-
D activity was detected in all the studied groups. No significant dif-
ferences were observed in ALA levels and ALA-S activity, while HO 
activity was 200% (p<0.05) induced in Hfe-/- males [Fig-3b]. 
ALA only induced HO activity in male Hfe-/- while all the other pa-
rameters measured were unchanged [Fig-3c]. 
Drug Metabolism System 
In [Table-3] are shown basal levels of CYP2E1 and GST activity of 
control and Hfe-/- mice. 
CYP2E1 activity was 36% (p<0.05) less in female mice of Hfe-/- 
respect to control group; without differences in male groups or be-
tween sex. 
Table 3- Basal levels of CYP2E1 and GST activities 
The group of Hfe-/- male mice had a basal activity of GST 35% 
(p<0.05) higher than controls. Moreover, in the both groups of fe-
males, GST activity was 40-50% (p<0.05) lesser than the respective 
male mice group. 
In animals receiving Isoflurane CYP2E1 activity was 48% (p<0.05) 
induced in male control mice and in male (28%, p<0.05) and female 
(54%, p<0.05) Hfe-/- group. GST activity was 68% (p<0.05) in-
creased in female control group, without any alteration in the other 
studied groups [Fig-4a]. 
No effect on CYP2E1 and GST activity was produced by ethanol 
administration [Fig-4b]. 
CYP2E1 activity was also unchanged after ALA administration. 
GST activity was increased in female groups, control and Hfe-/- 
treated with ALA; this response was not observed in male mice [Fig
-4c]. 
Discussion 
Considering that the participation of iron in the Fenton reaction will 
eventually induce the formation of ROS, the aim of this work was 
first compare basal levels of oxidative stress markers in the mice 
model of hemochromatosis respect to the wild type mice. To this 
end GSH, TAC and the activities of Catalase and SOD were meas-
ured. 
We have found that the levels of GSH and the activities of Catalase 
in males were reduced indicating that, in this murine model of he-
mochromatosis, the antioxidant defence system was altered. How-
ever in female mice, although Catalase activity was also diminished 
respect to the wild type group, TAC and GSH levels were higher 
than controls suggesting an enhancement in the machinery against 
the oxidative stress. 
Because ALA-S is the regulatory enzyme of heme biosynthesis and 
Fe is also involved in its regulation in erythroid cells, it was also of 
interest to measure this enzyme activity. Moreover, recalling that 
Catalase and NOS are hemeproteins, we wished to determine if 
there was any alteration in the regulatory heme pool that could af-
fect the synthesis of these hemeproteins. The activity of PBG-D, 
enzyme which is diminished in AIP patients in whom the levels of 
ALA and porphobilinogen are elevated during the acute attack, was 
determined. And to further characterized the instauration of oxida-
tive stress, the activity of HO, the rate-limiting enzyme in heme 
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GROUP SEX CYP2E1 nmol/mg GST nmol/mg 
Control 
Males 
15.220 ± 4.983 14.027 ± 2.768 
Hfe-/- 15.773 ± 1.237 19.174 ± 2.801* 
Control 18.58 ± 0.624 6.902 ± 2.365 
Females 
Hfe-/- 11.649 ± 2.702* 7.827 ± 1.933 
*p<0.05, significance of differences between Hfe-/- group respect to control group.  
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degradation and frequently induced under stress status, was meas-
ured. 
Fig. 4- CYP2E1 and GST activities in animals treated with Isoflu-
rane (a), ethanol (b) and ALA (c) 
No treated animals.        Treated animals. GST: Glutha-
tione S-transferase. Data represent mean value ± s.d. of at least 4-
6 animals. p<0.05, significance of differences between treated and 
non treated mice. 
In [Fig-4] are shown the results obtained when animals received 
Isoflurane, ethanol or ALA. 
Male Hfe-/- mice showed a high activity of ALA-S and PBG-D which 
would lead to increased heme synthesis, more available for the 
synthesis of hemeproteins such as Catalase which instead we have 
found, diminished. In the female group, ALA-S was also augmented 
nevertheless no differences were observed in PBG-D activity. Inter-
estingly, in female mice, the activity of HO was lower than in male 
group. We can propose two hypothesis to explain these findings, 
one would indicate that a low activity of HO could not be sufficient 
to degrade the heme necessary for the synthesis of the hemepro-
teins; other possibility is that liberation of iron, product of heme 
degradation by HO would not occur. 
The heme metabolism and the drug metabolizing system are relat-
ed by means of the hemeprotein CYP, being the isoform CYP2E1 
involved in the metabolization of Isoflurane and ethanol. So to com-
plete this work, the activity of this CYP2E1 was also measured. 
Moreover to evaluate if there were any hepatic damage, the activity 
of GST, enzyme of Phase II metabolism, was quantified. We have 
found that GST activity increased only in Hfe-/- male mice. In a Pro-
teomic study, Moran-Jimenez et al demonstrated an enhancement 
in the levels of this protein (unpublished data). 
When we evaluated the effect of porphyrinogenic drugs, Isoflurane 
and ethanol, results were different depending on the drug and the 
sex. Both xenobiotics altered heme metabolism showing a diminu-
tion on PBG-D activity and an increase in HO activity. The induction 
of HO would indicate a potentiation of oxidative stress that was 
more drastic due to ethanol administration because this drug also 
causes an induction of SOD activity. 
The alterations produced by Isoflurane on heme synthesis in the 
murine model of HH were similar to those observed when this an-
aesthetic was administered to CF1 mice [16] and added to a culture 
of a cell line established from hepatoerythropoietic porphyria pa-
tients [22] although, unexpectedly, induction of ALA-S did not occur. 
Instead, more recently we have found that giving Isoflurane to a 
genetic model of Erythropoietic Protoporphyria, ALA-S activity was 
strikingly induced, but reduction of PBG-D activity was not detected. 
Yet, we can not offer any plausible explanation for these differences 
in the response of ALA-S. We could speculate that due to the fact 
that in Hfe-/- mice, ALA-S basal activity was greatly increased with 
respect to the wild type group, HO was induced in CF1 mice liver 
after Isoflurane administration but not in the non acute porphyria 
models. 
The antioxidant defense system was altered too in animals receiv-
ing ALA. It was suggested that ALA produce ROS through oxidation 
catalyzed by iron [34, 35]. 
Findings here described would contribute to increase the 
knowledge about the association between HH and the Porphyrias 
and about the effects of volatile anaesthetics on different metabo-
lisms in genetic models of Porphyrias and associated diseases. 
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